Merck's Keytruda wins FDA approval to treat head and neck cancer
Merck & Co Inc said on Tuesday its blockbuster cancer drug Keytruda won approval from the U.S. Food and Drug Administration to treat a type of head and neck cancer.
from Reuters: Health News https://reut.rs/2wM9UMm
http://bit.ly/2zwRqiM